Skip to content

Proparacaine

Local Anesthetic — SENSORY ORGANS

Also known as: ophthaine, proparacaine HCl, proparacaine hydrochloride, proxymetacaine

OfpFDA approvedATC S01HA04

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Proparacaine is an ofp drug in the Local Anesthetic class catalogued in DrugCentral. It was first approved by the FDA in 1953. DrugCentral lists 4 molecular targets, including SIGMAR1, MAOA and SCN1A|SCN2A|SCN3A. Recorded indications include Administration of Corneal Anesthesia and Local Anesthesia for Ophthalmologic Procedure.

  • Approval status: ofp (first approved 1953 by the FDA).
  • Drug class: Local Anesthetic.
  • Molecular targets: SIGMAR1, MAOA, SCN1A|SCN2A|SCN3A and SCN10A (4 listed in DrugCentral).
  • Indications: Administration of Corneal Anesthesia and Local Anesthesia for Ophthalmologic Procedure.
  • ATC code: S01HA04 (Local anesthetics).
  • Molecular formula: C16H26N2O3; molecular weight 294.39 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (2)

  • Administration of Corneal Anesthesia
  • Local Anesthesia for Ophthalmologic Procedure

Contraindications (4)

  • Eye infection
  • Heart disease
  • Hyperthyroidism
  • Uveitis

Mechanism & targets

Established pharmacologic classLocal Anesthetic

Molecular targets (4)

TargetGeneActionActivity
Sigma non-opioid intracellular receptor 1SIGMAR1unknownKi 7.00
Amine oxidase [flavin-containing] AMAOAunknownIC50 5.75
Sodium channel alpha subunits; brain (Types I, II, III)SCN1A|SCN2A|SCN3AblockerIC50 5.72
Sodium channel protein type 10 subunit alphaSCN10Ablocker—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1953-07-01FDA——

ATC classification

ATC codeTherapeutic hierarchy
S01HA04SENSORY ORGANS › OPHTHALMOLOGICALS › LOCAL ANESTHETICS › Local anesthetics

Reported adverse-event signals

Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.

MedDRA termLLR
Conjunctival hyperaemia359.5
Hypopyon337.3
Corneal oedema319.8
Corneal epithelium defect304.8
Endophthalmitis220.8
Retinopathy of prematurity216.9
Keratopathy213.9
Corneal infiltrates211.1
Persistent corneal epithelial defect208.0
Ulcerative keratitis202.4
Eye pain188.6
Visual acuity reduced177.7

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Proparacaine is on its molecule page.

Molecular formulaC16H26N2O3
Molecular weight294.39 g/mol
CAS number499-67-2
InChIKeyKCLANYCVBBTKTO-UHFFFAOYSA-N
PubChem CID4935
CCCOC1=C(N)C=C(C=C1)C(=O)OCCN(CC)CC

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Proparacaine used for?

DrugCentral lists the following indications for Proparacaine: Administration of Corneal Anesthesia and Local Anesthesia for Ophthalmologic Procedure.

How does Proparacaine work?

Its molecular targets in DrugCentral include SIGMAR1, MAOA, SCN1A|SCN2A|SCN3A (blocker) and SCN10A (blocker).

When was Proparacaine first approved?

Proparacaine was first approved by the FDA in 1953.

What drug class does Proparacaine belong to?

Proparacaine is in the Local Anesthetic class.

What is the chemical formula of Proparacaine?

Proparacaine has the molecular formula C16H26N2O3 and a molecular weight of 294.39 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

StatusOFP
First approval1953-07-01
AgencyFDA
Targets4
Indications2
FormulaC16H26N2O3
DrugCentral ID2294
Interactive profile